Onconetix
ONCO
5 hedge funds and large institutions have $4.03M invested in Onconetix in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.
150% more funds holding
Funds holding: 2 → 5 (+3)
70% more capital invested
Capital invested by funds: $2.37M → $4.03M (+$1.66M)
0% more ownership
Funds ownership: 0% → 0% (+0%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$2.19M |
| 2 |
AFG
American Financial Group
Cincinnati,
Ohio
|
+$438K |
| 3 |
CAN
Cetera Advisor Networks
El Segundo,
California
|
+$438K |
| 4 |
Renaissance Technologies
New York
|
+$438K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$438K |
| 2 |
VF
Virtu Financial
New York
|
-$52K |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$14K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$7K |
ONCO Hedge Fund Activity: Q3 2022 in Review
5 of the 5,827 institutional investors tracked by Wall St. Rank reported a position in Onconetix (ONCO) for Q3 2022, worth a combined $4.03M — up 70% from $2.37M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new ONCO positions and 0 closed out — a net gain of 3 holders — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Armistice Capital, opening a new position worth an estimated $2.19M. The largest seller was Sabby Management, cutting an estimated $438K.
- 5 institutional investors held Onconetix (ONCO) as of Q3 2022, up from 2 in Q2 2022.
- Funds reported $4.03M of Onconetix stock for Q3 2022, up 70% quarter-over-quarter.
- 3 funds opened new Onconetix positions in Q3 2022 and 0 closed out, a net change of +3 holders.
- The largest Onconetix buyer in Q3 2022 was Armistice Capital, an estimated $2.19M added.
- The largest Onconetix seller in Q3 2022 was Sabby Management, an estimated $438K sold.
Based on aggregated 13F filings for Q3 2022.